CorDx Combo Flu, RSV, COVID-19 Self-Test Gains EU Nod
By Sam Brusco, Associate Editor | 06.03.22
According to the company, it's the first test of its kind in the world.
CorDx was granted CE mark approval for the world’s first combined self-test for influenza A, influenza B, COVID-19, and Respiratory Syncytial Virus (RSV).
The Influenza A/B+COVID-19/RSV Combo Ag Test allows detection of all four infections in a single, self-administered test. These infections often manifest with similar symptoms.
"As COVID-19 infection prevention measures relax globally, COVID and other viral infections are projected to rise. CorDx's Influenza A/B+COVID-19/RSV Combo Ag self-test can detect all four infections in one easy-to-use test," Jeff Yufeng Li, CorDx's founder and CEO told the press. "We're excited to introduce this important new diagnostic tool to families and healthcare providers in the EU."
CorDx is a member of the CorDx Union, a biotechnology organization that delivers medical device solutions to healthcare industries and over a billion users in more than 170 countries.
The Influenza A/B+COVID-19/RSV Combo Ag Test allows detection of all four infections in a single, self-administered test. These infections often manifest with similar symptoms.
"As COVID-19 infection prevention measures relax globally, COVID and other viral infections are projected to rise. CorDx's Influenza A/B+COVID-19/RSV Combo Ag self-test can detect all four infections in one easy-to-use test," Jeff Yufeng Li, CorDx's founder and CEO told the press. "We're excited to introduce this important new diagnostic tool to families and healthcare providers in the EU."
CorDx is a member of the CorDx Union, a biotechnology organization that delivers medical device solutions to healthcare industries and over a billion users in more than 170 countries.
